Quarterly report · Q3
9273.TEDINET S100TEGN
Period2023-07-01 → 2024-03-31
Filed2024-05-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥16.8bn | 2023-07-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥22.1bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.2bn | 2022-07-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥3.6bn | 2023-07-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥3.3bn | 2022-07-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥3.6bn | 2023-07-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.1bn | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.2bn | 2022-07-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥3.6bn | 2023-07-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.2bn | 2022-07-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.3bn | 2023-07-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.7bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.1bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.3bn | 2023-07-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥2.1bn | 2022-07-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥30.0bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥28.5bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥27.5bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.3bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥7.5bn | at 2023-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥22.7bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥20.9bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥20.3bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.7bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.8bn | at 2023-06-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥57.1 | 2023-07-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.64 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥67.83 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.48 | 2022-07-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.29 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 75.7% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.5% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-07-01 → 2024-03-31 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-07-01 → 2024-03-31 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2023-07-01 → 2024-03-31 | −¥11m |
| jpcrp040300-q3r_E34071-000Drug Substance Sales Businessreportable segment | revenue | 2023-07-01 → 2024-03-31 | ¥11.5bn |
| jpcrp040300-q3r_E34071-000Drug Substance Sales Businessreportable segment | revenue external | 2023-07-01 → 2024-03-31 | ¥10.3bn |
| jpcrp040300-q3r_E34071-000Drug Substance Sales Businessreportable segment | revenue intersegment | 2023-07-01 → 2024-03-31 | ¥1.3bn |
| jpcrp040300-q3r_E34071-000Drug Substance Sales Businessreportable segment | segment profit | 2023-07-01 → 2024-03-31 | ¥2.1bn |
| jpcrp040300-q3r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue | 2023-07-01 → 2024-03-31 | ¥6.5bn |
| jpcrp040300-q3r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue external | 2023-07-01 → 2024-03-31 | ¥6.5bn |
| jpcrp040300-q3r_E34071-000Pharmaceutical Marketing Businessreportable segment | segment profit | 2023-07-01 → 2024-03-31 | ¥1.5bn |
| —segment total | revenue | 2023-07-01 → 2024-03-31 | ¥18.0bn |
| —segment total | revenue external | 2023-07-01 → 2024-03-31 | ¥16.8bn |
| —segment total | revenue intersegment | 2023-07-01 → 2024-03-31 | ¥1.3bn |
| —segment total | segment profit | 2023-07-01 → 2024-03-31 | ¥3.6bn |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-03-31 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-03-31 | −¥1.4bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-03-31 | ¥16m |
| jpcrp040300-q3r_E34071-000Drug Substance Sales Businessreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥11.5bn |
| jpcrp040300-q3r_E34071-000Drug Substance Sales Businessreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥10.2bn |
| jpcrp040300-q3r_E34071-000Drug Substance Sales Businessreportable segment | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥1.4bn |
| jpcrp040300-q3r_E34071-000Drug Substance Sales Businessreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥2.0bn |
| jpcrp040300-q3r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue | 2022-07-01 → 2023-03-31 | ¥6.0bn |
| jpcrp040300-q3r_E34071-000Pharmaceutical Marketing Businessreportable segment | revenue external | 2022-07-01 → 2023-03-31 | ¥6.0bn |
| jpcrp040300-q3r_E34071-000Pharmaceutical Marketing Businessreportable segment | segment profit | 2022-07-01 → 2023-03-31 | ¥1.2bn |
| —segment total | revenue | 2022-07-01 → 2023-03-31 | ¥17.5bn |
| —segment total | revenue external | 2022-07-01 → 2023-03-31 | ¥16.2bn |
| —segment total | revenue intersegment | 2022-07-01 → 2023-03-31 | ¥1.4bn |
| —segment total | segment profit | 2022-07-01 → 2023-03-31 | ¥3.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 356
| Item | Context | Value | Unit |
|---|---|---|---|
| Total number of shares held treasury shares etc | CurrentQuarterInstant_Row1Member | 1300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant_Row1Member | 0.0000 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant | 1300 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant | - | |
| Total number of shares held treasury shares etc | CurrentQuarterInstant | 1300 | |
| Shareholding ratio treasury shares etc | CurrentQuarterInstant | 0.0000 | |
| Cash and deposits | Prior1YearInstant | 10767016000 | JPY |
| Cash and deposits | CurrentQuarterInstant | 10687951000 | JPY |
| Notes and accounts receivable trade | Prior1YearInstant | 3910453000 | JPY |
| Notes and accounts receivable trade | CurrentQuarterInstant | 4063389000 | JPY |
| Electronically recorded monetary claims operating ca | Prior1YearInstant | 4406195000 | JPY |
| Electronically recorded monetary claims operating ca | CurrentQuarterInstant | 5209870000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 1415639000 | JPY |
| Merchandise and finished goods | CurrentQuarterInstant | 1524124000 | JPY |
| Work in process | Prior1YearInstant | 563125000 | JPY |
| Work in process | CurrentQuarterInstant | 501840000 | JPY |
| Raw materials and supplies | Prior1YearInstant | 483358000 | JPY |
| Raw materials and supplies | CurrentQuarterInstant | 612121000 | JPY |
| Other ca | Prior1YearInstant | 284469000 | JPY |
| Other ca | CurrentQuarterInstant | 98741000 | JPY |
| Current assets | Prior1YearInstant | 21830258000 | JPY |
| Current assets | CurrentQuarterInstant | 22698038000 | JPY |
| Buildings and structures | Prior1YearInstant | 4889478000 | JPY |
| Buildings and structures | CurrentQuarterInstant | 5639078000 | JPY |
| Accumulated depreciation buildings and structures | Prior1YearInstant | -2336069000 | JPY |
| Accumulated depreciation buildings and structures | CurrentQuarterInstant | -2487252000 | JPY |
| Buildings and structures net | Prior1YearInstant | 2553408000 | JPY |
| Buildings and structures net | CurrentQuarterInstant | 3151825000 | JPY |
| Machinery equipment and vehicles | Prior1YearInstant | 3798624000 | JPY |
| Machinery equipment and vehicles | CurrentQuarterInstant | 3836193000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | Prior1YearInstant | -2267079000 | JPY |
| Accumulated depreciation machinery equipment and vehicles | CurrentQuarterInstant | -2562456000 | JPY |
| Machinery equipment and vehicles net | Prior1YearInstant | 1531544000 | JPY |
| Machinery equipment and vehicles net | CurrentQuarterInstant | 1273737000 | JPY |
| Tools furniture and fixtures | Prior1YearInstant | 1351945000 | JPY |
| Tools furniture and fixtures | CurrentQuarterInstant | 1436746000 | JPY |
| Accumulated depreciation tools furniture and fixtures | Prior1YearInstant | -1085743000 | JPY |
| Accumulated depreciation tools furniture and fixtures | CurrentQuarterInstant | -1147121000 | JPY |
| Tools furniture and fixtures net | Prior1YearInstant | 266201000 | JPY |
| Tools furniture and fixtures net | CurrentQuarterInstant | 289625000 | JPY |
| Land | Prior1YearInstant | 1761774000 | JPY |
| Land | CurrentQuarterInstant | 1761774000 | JPY |
| Construction in progress | Prior1YearInstant | 163026000 | JPY |
| Construction in progress | CurrentQuarterInstant | 475985000 | JPY |
| Property plant and equipment | Prior1YearInstant | 6275955000 | JPY |
| Property plant and equipment | CurrentQuarterInstant | 6952946000 | JPY |
| Other ia | Prior1YearInstant | 33879000 | JPY |
| Other ia | CurrentQuarterInstant | 17630000 | JPY |
| Intangible assets | Prior1YearInstant | 33879000 | JPY |
| Intangible assets | CurrentQuarterInstant | 17630000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |